Literature DB >> 4027942

Surgical treatment of punctal-canalicular fibrosis from 5-fluorouracil therapy.

S R Seiff, N Shorr, T Adams.   

Abstract

5-Fluorouracil (5-FU) has been reported to cause punctal-canalicular fibrosis with resultant severe epiphora. It is reported that the epiphora will often resolve when treatment ceases or is decreased. However, this report describes a case of punctal-canalicular fibrosis so severe that bilateral conjunctivodacryocystorhinostomies were necessary. This has not been previously reported to the best of the authors' knowledge. It is recommended that ophthalmic consultation be obtained for patients in whom long-term 5-FU therapy is anticipated or who develop tearing while on therapy.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4027942     DOI: 10.1002/1097-0142(19851015)56:8<2148::aid-cncr2820560845>3.0.co;2-r

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

1.  Dacryoendoscopic observation and incidence of canalicular obstruction/stenosis associated with S-1, an oral anticancer drug.

Authors:  Tsugihisa Sasaki; Hiroaki Miyashita; Tamon Miyanaga; Katsushi Yamamoto; Kazuhisa Sugiyama
Journal:  Jpn J Ophthalmol       Date:  2012-03-13       Impact factor: 2.447

Review 2.  Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature.

Authors:  H M Brink; L V Beex
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

3.  Assessment and management of proximal and incomplete symptomatic obstruction of the lacrimal drainage system.

Authors:  Mohsen Bahmani Kashkouli; Farzad Pakdel; Victoria Kiavash
Journal:  Middle East Afr J Ophthalmol       Date:  2012-01

4.  Management of acquired punctal stenosis with perforated punctal plugs.

Authors:  Ozlen Rodop Ozgur; Levent Akcay; Nesrin Tutas; Onur Karadag
Journal:  Saudi J Ophthalmol       Date:  2015-05-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.